InventisBio Co. Ltd. A (688382 SHG) stock market data APIs
¥28.8167
-0.72(-2.5%)
as of December 8, 2025
Try our APIs with
free plan!
InventisBio Co. Ltd. A Financial Data Overview
Price chart is built with
Anychart
InventisBio Co., Limited, a clinical stage biotech company, engages in the discovery and development of therapeutics for cancer and metabolic diseases in China. The company's drug candidates for the oncology therapeutic area include BPI-D0316, which is in Phase III clinical trial for the non-small cell lung cancer (NSCLS) indications; Taragarestrant, which is in Phase III clinical trial for the treatment of estrogen receptor positive and human epidermal growth factor receptor 2 (HER2)-negative breast cancer; and Gesorexel, which in Phase II clinical trial to treat various cancers, such as non-small cell lung cancer and colorectal cancer with KRASG12C mutations. Its drug candidates for the metabolic therapeutic area is D-0120, a Phase II clinical trial product for hyperuricemia and gout indications; and D-2570, a oral selective inhibitor for the treatment of autoimmune diseases such as psoriasis. In addition, the company offers preclinical products, including YF 087 for MSI high cancers, and YF550 for chromosome instability cancers. InventisBio Co., Limited was founded in 2013 and is headquartered in Pudong, China.
Prev. Close
28.8167
Open
28.093
High
29.3101
Low
27.7344
52 wk Range
11.03-49.68
Market Cap
16 240 M
Shares Outstanding
578 M
Revenue
181 M
EPS
-0.205
Beta
0.283
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get InventisBio Co. Ltd. A data using free add-ons & libraries
Get InventisBio Co. Ltd. A Fundamental Data
InventisBio Co. Ltd. A Fundamental data includes:
- Net Revenue: 181 M
- EBITDA: -163 047 440
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2023-04-25
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
InventisBio Co. Ltd. A News
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
